PEAK6 Investments’s Advent Technologies ADN Stock Holding History

PEAK6 Investments’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-184	Closed	-$44.8K	–	5055
2021 Q2	$53K	Buy	+184	New	+$61.2K	﹤0.01%	4584

Other funds holding ADN

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

PEAK6 Investments's ADN Position: Q3 2021 in Review

PEAK6 Investments sold out of Advent Technologies (ADN) in Q3 2021, closing a stake of 184 shares — an estimated $44.8K sold.

PEAK6 Investments first reported a position in ADN in Q2 2021 and held it in 1 quarter. The position peaked at $53K in Q2 2021. 51 funds tracked by Wall St. Rank hold ADN as of Q3 2021.

PEAK6 Investments reported no remaining Advent Technologies position as of Q3 2021 after selling out during the quarter.
PEAK6 Investments sold 184 Advent Technologies shares in Q3 2021, an estimated $44.8K.
PEAK6 Investments first reported a position in Advent Technologies in Q2 2021 and held it in 1 quarter.
PEAK6 Investments's Advent Technologies position peaked at $53K in Q2 2021.
51 funds tracked by Wall St. Rank held Advent Technologies as of Q3 2021.

Based on PEAK6 Investments's 13F filing for Q3 2021, filed 12 Nov 2021.